Stock Code: 002675 Stock Abbreviation: Dongcheng Pharmaceutical Announcement No.: 2026-044
Yantai Dongcheng Pharmaceutical Group Co., Ltd. Announcement on Re-submission of Application for H-Share Listing by Subsidiary Yantai Blue-Nac Biotechnology Co., Ltd. to the Hong Kong Stock Exchange and Publication of Application Materials
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.
Yantai Dongcheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Dongcheng Pharmaceutical" or the "Company") is currently undertaking the spin-off of its subsidiary, Yantai Blue-Nac Biotechnology Co., Ltd. (hereinafter referred to as "Blue-Nac"), for listing on the Main Board of The Stock Exchange of Hong Kong Limited (hereinafter referred to as the "Hong Kong Stock Exchange") (hereinafter referred to as the "Spin-off").